Shares of Arcturus Therapeutics dropped 9.36% to $54.01 at 15:28 EST on Tuesday, following last session’s downward trend. NASDAQ Composite is falling 1.28% to $13,360.07, following last session’s downward trend, This seems, as yet, an all-around rough trend trading session today.

Arcturus Therapeutics’s last close was $59.59, 140.16% below its 52-week high of $129.71.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is a negative 20.5% for the ongoing quarter and 223.5% for the next. The company’s growth estimates for the present quarter and the next is a negative 15.8% and a negative 4.5%, respectively.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 29.7%, now sitting on 10.27M for the twelve trailing months.


Arcturus Therapeutics’s last day, last week, and last month’s average volatility was 12.40%, 5.78%, and 5.06%, respectively.

Arcturus Therapeutics’s last day, last week, and last month’s high and low average amplitude percentage was 10.17%, 7.71%, and 9.02%, respectively.

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $54.01 at 15:28 EST, way below its 52-week high of $129.71 and way higher than its 52-week low of $8.51.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s value is way below its 50-day moving average of $69.23 and way below its 200-day moving average of $62.28.


Please enter your comment!
Please enter your name here